{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:00:15Z","timestamp":1790226015966,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.reumae.2020.06.011","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T17:08:14Z","timestamp":1616087294000},"page":"582-587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Infections in systemic autoimmune diseases"],"prefix":"10.1016","volume":"17","author":[{"given":"Sandra Andrea","family":"Consani Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Laura","family":"D\u00edaz Cu\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Fern\u00e1ndez Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda","family":"Rost\u00e1n Sellanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Maciel Oleggini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Antonio","family":"Facal Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2020.06.011_bib0005","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a com- parison of early and late manifestations in a cohort of 1000 patients","volume":"82","author":"Cervera","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.reumae.2020.06.011_bib0010","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.idc.2006.09.007","article-title":"Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis\/ dermatomyositis","volume":"20","author":"Alarc\u00f3n","year":"2006","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.reumae.2020.06.011_bib0015","first-page":"1559","article-title":"Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort","volume":"19","author":"Petri","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2020.06.011_bib0020","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1177\/0961203308101019","article-title":"Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality","volume":"18","author":"Goldblatt","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.reumae.2020.06.011_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.md.0000104742.42401.e2","article-title":"The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus ethnic and disease heterogeneity among \u201cHispanics\u201d","volume":"83","author":"Pons Estel","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.reumae.2020.06.011_bib0030","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.rdc.2012.08.019","article-title":"Infections and biologic therapy in rheumatoid arthritis. Our changing understanding of risk and prevention","volume":"38","author":"Winthrop","year":"2012","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.reumae.2020.06.011_bib0035","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4081\/reumatismo.2018.1106","article-title":"Extra-articular rheumatoid arthritis","volume":"70","author":"Marcucci","year":"2018","journal-title":"Reumatismo"},{"key":"10.1016\/j.reumae.2020.06.011_bib0040","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1136\/annrheumdis-2015-207841","article-title":"Opportunistic infections and biological therapies in immune-mediated inflammatory diseases: consensus recomendations for infection reporting during clinical trials and postmarketing surveillance","volume":"74","author":"Winthrop","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2020.06.011_bib0045","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/cid\/ciu185","article-title":"Biologic therapies in rheumatoid arthritis and the risk of opportunistic infections: a meta-analysis","volume":"58","author":"Kourbeti","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.reumae.2020.06.011_bib0050","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.rdc.2012.08.016","article-title":"Non serious infections: should there be cause for serious concerns?","volume":"38","author":"Dao","year":"2012","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.reumae.2020.06.011_bib0055","first-page":"1180","article-title":"Infection and disease activity in systemic lupus erythematosus: A review of hospitalized patients","volume":"18","author":"Duffy","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2020.06.011_bib0060","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1191\/096120301678416088","article-title":"Infections in outpatients with systemic lupus erythematosus: a prospective study","volume":"10","author":"Zonana-Nacach","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.reumae.2020.06.011_bib0065","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1191\/0961203302lu170oa","article-title":"The nature and outcome of infection in systemic lupus erythematosus","volume":"11","author":"Gladman","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.reumae.2020.06.011_bib0070","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1177\/0961203306071919","article-title":"Infections in Systemic lupus erythematosus: a prospective and controlled study of 110 patients","volume":"15","author":"Bosch","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.reumae.2020.06.011_bib0075","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/00365540902744741","article-title":"Incidence and risk factors of infection in a single cohort of 110 adults with systemic lupus erythematosus","volume":"41","author":"Jeong","year":"2009","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.reumae.2020.06.011_bib0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/ar2764","article-title":"Predictors of major infections in systemic lupus erythematosus","volume":"11","author":"Ruiz-Irastorza","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.reumae.2020.06.011_bib0085","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.10524","article-title":"Frecuency of infection in patients with rheumatoid arthritis compared with controls: a population-based study","volume":"46","author":"Doran","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2020.06.011_bib0090","first-page":"127","article-title":"The incidence and clinical characteristics of Mycobacterium tuberculosis infection among systemic lupus erythematosus and rheumatoid arthritis patients in Korea","volume":"20","author":"Yun","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.reumae.2020.06.011_bib0095","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1191\/0961203303lu529xx","article-title":"Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localization","volume":"13","author":"Sayarlioglu","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.reumae.2020.06.011_bib0100","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/030097402760375205","article-title":"Risk factors and clinical features for tuberculosis among patients with systemic lupus ery-thematosus in Hong Kong","volume":"31","author":"Tam","year":"2002","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.reumae.2020.06.011_bib0105","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1191\/0961203306lu2289xx","article-title":"High risk of tuberculosis in systemic lupus erythematosus?","volume":"15","author":"Erdozain","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.reumae.2020.06.011_bib0110","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/ard.2006.068676","article-title":"Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort","volume":"66","author":"Alarc\u00f3n","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2020.06.011_bib0115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.2008.101766","article-title":"Clinical effects and side effects of antimalarials in systemic lupus erythematosus: a systematic review","volume":"69","author":"Ruiz-Irastorza","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2020.06.011_bib0120","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/08916930500285352","article-title":"Infections and SLE","volume":"38","author":"Zandman-Goddard","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.reumae.2020.06.011_bib0125","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1136\/ard.2011.151043","article-title":"Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?","volume":"70","author":"Strangfeld","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2020.06.011_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/rmdopen-2016-000352","article-title":"No impact of concomitant methotrexate use on serious adverse event and serious infection risk in patients with rheumatoid arthritis treated with bDMARDs: a systematic literature review and metaanalysis","volume":"3","author":"Baradat","year":"2017","journal-title":"RMD Open"},{"key":"10.1016\/j.reumae.2020.06.011_bib0135","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.reuma.2010.04.002","article-title":"Grupo de Estudio BIOBADASER Biobadaser 2.0: an\u00e1lisis y tendencias en 2009","volume":"6","author":"Descalzo","year":"2010","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.reumae.2020.06.011_bib0140","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MD.0b013e318190f170","article-title":"A systematic review of the off-label use of biological therapies in systemic autoimmune diseases","volume":"87","author":"Ramos-Casals","year":"2008","journal-title":"Medicine"},{"key":"10.1016\/j.reumae.2020.06.011_bib0145","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3904\/kjim.2016.234","article-title":"Infection in systemic lupus erythematosus similarities, and differencs with lpus flare","volume":"32","author":"Jung","year":"2017","journal-title":"Korean J intern Med"},{"key":"10.1016\/j.reumae.2020.06.011_bib0150","first-page":"142","article-title":"Vacunaci\u00f3n en terapias inmunosupresoras","volume":"2","author":"Rodriguez","year":"2018","journal-title":"Rev Urug Med Int"}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574321000575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574321000575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:00:47Z","timestamp":1761879647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574321000575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2173574321000575"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2020.06.011","relation":{},"ISSN":["2173-5743"],"issn-type":[{"value":"2173-5743","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infections in systemic autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2020.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2020.06.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}